These pioneers are aiming to do challenging and important medical work. One has already implanted 54 patients.

Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology. It is the only company to have obtained FDA approval of a device providing artificial vision ...

Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology. It is the only ...

Cerebral/Cortical Visual Impairment (CVI) is the most common cause of childhood blindness, but it is often left undiagnosed. A State House awareness day set the groundwork for changing that.

LEXINGTON — Morgan Roszman isn’t ready to go to school and see her friends. So her friends — and many other community members — came to see her on Wednesday, the first day of the new school year for ...

SAVANNAH, Ga. (WTOC) - You can celebrate the strength, independence, and resilience of people living with blindness or visual impairments in our community at the 2025 Walk a Mile in My Shoes event.

An appellate court on July 10 upheld a $207.6 million verdict against the Hospital of the University of Pennsylvania, affirming a lower court’s finding that a delayed cesarean section caused a child ...

Cerebral/Cortical visual impairment (CVI), a brain-based visual condition, is a leading cause of childhood blindness and low vision but remains underdiagnosed in individuals with Down syndrome (DS).

UCB’s Fintepla has been approved to treat seizures associated with two epilepsy disorders and now has posted data that could pave the way for its use in another epilepsy condition. A phase 3 trial of ...